SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis

Molecular Biology of the Cell

Volumn 15, Issue 7, 2004, Pages 3309-3319

  Ellerbroek, Shawn M ^a   Wennerberg, Krister ^a,b   Arthur, William T ^c   Dunty, Jill M ^a   Bowman, Dan R ^a   DeMali, Kris A ^a   Der, Channing ^b   Burridge, Keith ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DEXTRAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; NUCLEOTIDE; PROLINE; PROTEIN SGEF; RAC PROTEIN; RECOMBINANT PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOG GUANINE NUCLEOTIDE EXCHANGE FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; FIBROBLAST; LIVER; MACROPINOCYTOSIS; MEMBRANE; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SCANNING ELECTRON MICROSCOPY;

ACTINS; ANIMALS; CELL LINE; FIBROBLASTS; GTP PHOSPHOHYDROLASES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; PINOCYTOSIS; POINT MUTATION; RHO GTP-BINDING PROTEINS;

ANIMALIA;

EID: 3042801758     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-02-0146     Document Type: Article

References (43)

1. Ando, S. et al. (1992). Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J. Biol. Chem. 267, 25709-25713.
2. Arthur, W.T., Ellerbroek, S.M., Der, C.J., Burridge, K., and Wennerberg, K. (2002). XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. J. Biol. Chem. 277, 42964-42972.
3. Blangy, A., Vignal, E., Schmidt, S., Debant, A., Gauthier-Rouviere, C., and Fort, P. (2000). TrioGEF1 controls Rac- and Cdc42-dependent cell structures through the direct activation of rhoG. J. Cell Sci. 113, 729-739.
4. Booden, M.A., Campbell, S.L., and Der, C.J. (2002). Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation. Mol. Cell. Biol. 22, 2487-2497.
5. Brunk, U., Collins, V.P., and Arro, E. (1981). The fixation, dehydration, drying and coating of cultured cells of SEM. J. Microsc. 123, 121-131.
6. Burridge, K., and Wennerberg, K. (2004). Rho and Rac take center stage. Cell 116, 167-179.
7. Chen, L.M., Hobbie, S., and Galan, J.E. (1996). Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses. Science 274, 2115-2118.
8. Debily, M.A. et al. (2004). Expression and molecular characterization of alternative transcripts of the ARHGEF5/TIM oncogene specific for human breast cancer. Hum. Mol. Genet. 13, 323-334.
9. Dharmawardhane, S., Sanders, L.C., Martin, S.S., Daniels, R.H., and Bokoch, G.M. (1997). Localization of p21-activated kinase 1 (PAK1) to pinocytic vesicles and cortical actin structures in stimulated cells. J. Cell Biol. 138, 1265-1278.
10. Dharmawardhane, S., Schurmann, A., Sells, M.A., Chernoff, J., Schmid, S.L., and Bokoch, G.M. (2000). Regulation of macropinocytosis by p21-activated kinase-1. Mol. Biol. Cell 11, 3341-3352.
11. Ellerbroek, S.M., Wennerberg, K., and Burridge, K. (2003). Serine phosphorylation negatively regulates RhoA in vivo. J. Biol. Chem. 278, 19023-19031.
12. Estrach, S., Schmidt, S., Diriong, S., Penna, A., Blangy, A., Fort, P., and Debant, A. (2002). The Human Rho-GEF trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth. Curr. Biol. 12, 307-312.
13. Garrett, W.S., Chen, L.M., Kroschewski, R., Ebersold, M., Turley, S., Trombetta, S., Galan, J.E., and Mellman, I. (2000). Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102, 325-334.
14. Gauthier-Rouviere, C., Vignal, E., Meriane, M., Roux, P., Montcourier, P., and Fort, P. (1998). RhoG GTPase controls a pathway that independently activates Rac1 and Cdc42Hs. Mol. Biol. Cell 9, 1379-1394.
15. Groysman, M., Nagano, M., Shaanan, B., and Katzav, S. (1998). Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation. Oncogene 17, 1597-1606.
16. Hing, H., Xiao, J., Harden, N., Lim, L., and Zipursky, S.L. (1999). Pak functions downstream of Dock to regulate photoreceptor axon guidance in Drosophila. Cell 97, 853-863.
17. Hobert, O., Schilling, J.W., Beckerle, M.C., Ullrich, A., and Jallal, B. (1996). SH3 domain-dependent interaction of the proto-oncogene product Vav with the focal contact protein zyxin. Oncogene 12, 1577-1581.
18. Johannes, L., and Lamaze, C. (2002). Clathrin-dependent or not: is it still the question? Traffic 3, 443-451.
19. Joyce, P.L., and Cox, A.D. (2003). Rac1 and Rac3 are targets for geranylgeranyltransferase I inhibitor-mediated inhibition of signaling, transformation, and membrane ruffling. Cancer Res. 63, 7959-7967.
20. Katoh, H., Yasui, H., Yamaguchi, Y., Aoki, J., Fujita, H., Mori, K., and Negishi, M. (2000). Small GTPase RhoG is a key regulator for neurite outgrowth in PC12 cells. Mol. Cell. Biol. 20, 7378-7387.
21. Katoh, H., and Negishi, M. (2003). RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo. Nature 424, 461-464.
22. Katzav, S., Cleveland, J.L., Heslop, H.E., and Pulido, D. (1991). Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol. Cell. Biol. 11, 1912-1920.
23. Leonard, D.A., Evans, T., Hart, M., Cerione, R.A., and Manor, D. (1994). Investigation of the GTP-binding/GTPase cycle of Cdc42Hs using fluorescence spectroscopy. Biochemistry 33, 12323-12328.
24. Liu, B.P., and Burridge, K. (2000). Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins. Mol. Cell. Biol. 20, 7160-7169.
25. Marechal, V., Prevost, M.C., Petit, C., Perret, E., Heard, J.M., and Schwartz, O. (2001). Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 75, 11166-11177.
26. May, V., Schiller, M.R., Eipper, B.A., and Mains, R.E. (2002). Kalirin Dbl-homology guanine nucleotide exchange factor I domain initiates new axon outgrowths via RhoG-mediated mechanisms. J. Neurosci. 22, 6980-6990.
27. Moon, S.Y., and Zheng, Y. (2003). Rho GTPase-activating proteins in cell regulation. Trends Cell Biol. 13, 13-22.
28. Ohya, Y., Qadota, H., Anraku, Y., Pringle, J.R., and Botstein, D. (1993). Suppression of yeast geranylgeranyl transferase I defect by alternative prenylation of two target GTPases, Rho1p and Cdc42p. Mol. Biol. Cell 4, 1017-1025.
29. Olofsson, B. (1999). Rho guanine dissociation inhibitors: pivotal molecules in cellular signaling. Cell Signal. 11, 545-554.
30. Qi, H., Fournier, A., Grenier, J., Fillion, C., Labrie, Y., and Labrie, C. (2003). Isolation of the novel human guanine nucleotide exchange factor Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF) and of C-terminal SGEF, an N-terminally truncated form of SGEF, the expression of which is regulated by androgen in prostate cancer cells. Endocrinology 144, 1742-1752.
31. Ren, X.D., Kiosses, W.B., and Schwartz, M.A. (1999). Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18, 578-585.
32. Ridley, A.J., Paterson, H.F., Johnston, C.L., Diekmann, D., and Hall, A. (1992). The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70, 401-410.
33. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400.
34. Schlunck, G., Damke, H., Kiosses, W.B., Rusk, N., Symons, M.H., Waterman-Storer, C.M., Schmid, S.L., and Schwartz, M.A. (2004). Modulation of Rac localization and function by dynamin. Mol. Biol. Cell 15, 256-267.
35. Schmidt, A., and Hall, A. (2002). Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 16, 1587-1609.
36. Schuebel, K.E., Movilla, N., Rosa, J.L., and Bustelo, X.R. (1998). Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J. 17, 6608-6621.
37. van Leeuwen, F.N., van der Kammen, R.A., Habets, G.G., and Collard, J.G. (1995). Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells. Oncogene 11, 2215-2221.
38. Vigorito, E., Bell, S., Hebeis, B.J., Reynolds, H., McAdam, S., Emson, P.C., McKenzie, A., and Turner, M. (2004). Immunological function in mice lacking the Rac-related GTPase RhoG. Mol. Cell. Biol. 24, 719-729.
39. Vincent, S., Jeanteur, P., and Fort, P. (1992). Growth-regulated expression of rhoG, a new member of the ras homolog gene family. Mol. Cell. Biol. 12, 3138-3148.
40. Watarai, M., Derre, I., Kirby, J., Growney, J.D., Dietrich, W.F., and Isberg, R.R. (2001). Legionella pneumophila is internalized by a macropinocytotic uptake pathway controlled by the Dot/Icm system and the mouse Lgn1 locus. J. Exp. Med. 194, 1081-1096.
41. Wennerberg, K., Ellerbroek, S.M., Liu, R.Y., Karnoub, A.E., Burridge, K., and Der, C.J. (2002). RhoG signals in parallel with Rac1 and Cdc42. J. Biol. Chem. 277, 47810-47817.
42. West, M.A., Prescott, A.R., Eskelinen, E.L., Ridley, A.J., and Watts, C. (2000). Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr. Biol. 10, 839-848.
43. Ye, Z.S., and Baltimore, D. (1994). Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc. Natl. Acad. Sci. USA 91, 12629-12633.